Literature DB >> 23422761

Normocalcemic primary hyperparathyroidism: a newly emerging disease needing therapeutic intervention.

Gonzalo Díaz-Soto1, María Teresa Julián, Manel Puig-Domingo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23422761     DOI: 10.14310/horm.2002.1370

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


× No keyword cloud information.
  4 in total

1.  Polymorphisms of the vitamin D receptor and their effect on bone mass density in patients with normocalcemic hyperparathyroidism.

Authors:  Jose Luis Perez Castrillón; Gonzalo Díaz-Soto; Olatz Izaola Jauregui; Enrique Romero; Daniel de Luis Román
Journal:  Endocrine       Date:  2015-04-21       Impact factor: 3.633

2.  Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism.

Authors:  Patrícia Nunes Mesquita; Ana Paula Dornelas Leão Leite; Stella das Chagas Crisóstomo; Enio Veras Filho; Lucas da Cunha Xavier; Francisco Bandeira
Journal:  Vasc Health Risk Manag       Date:  2017-06-22

3.  Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.

Authors:  Selvihan Beysel; Mustafa Caliskan; Muhammed Kizilgul; Mahmut Apaydin; Seyfullah Kan; Mustafa Ozbek; Erman Cakal
Journal:  BMC Cardiovasc Disord       Date:  2019-05-08       Impact factor: 2.298

4.  Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study.

Authors:  Umberto Albert; David De Cori; Andrea Aguglia; Francesca Barbaro; Fabio Lanfranco; Filippo Bogetto; Giuseppe Maina
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-20       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.